UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Prevalence and Incidence of Uveitis: A Systematic Review and Meta-analysis

Ophthalmic epidemiology, 2021-11, Vol.28 (6), p.461-468

2021

Volltextzugriff (PDF)

Prevalence of uveitis in a Spanish population, UveCAM study

Medicina clinica, 2020-12, Vol.155 (11), p.506

2020

Volltextzugriff (PDF)

The effect of biologic therapy different from infliximab or adalimumab in patients with refractory uveitis due to Behçet's disease: results of a multicentre open-label study

Clinical and experimental rheumatology, 2016-09, Vol.34 (6 Suppl 102), p.S34

2016

Volltextzugriff (PDF)

Power Doppler ultrasonography assessment of entheses in spondyloarthropathies: response to therapy of entheseal abnormalities

Journal of rheumatology, 2010-10, Vol.37 (10), p.2110-2117

2010

Volltextzugriff (PDF)

Usefulness of Adalimumab in the Treatment of Refractory Uveitis Associated with Juvenile Idiopathic Arthritis

Mediators of Inflammation, 2013-01, Vol.2013 (2013), p.1020-1025-192

2013

Volltextzugriff (PDF)

Treatment of Refractory Uveitis with Adalimumab: A Prospective Multicenter Study of 131 Patients

Ophthalmology (Rochester, Minn.), 2012-08, Vol.119 (8), p.1575-1581

2012

Volltextzugriff (PDF)

Cardiovascular Screening Practices and Statin Prescription Habits in Patients with Psoriasis among Dermatologists, Rheumatologists and Primary Care Physicians

Acta dermato-venereologica, 2023-03, Vol.103, p.adv5087-adv5087

2023

Volltextzugriff (PDF)

Reduction of disease activity, corticosteroids use, and healthcare resource utilisation in patients with systemic lupus erythematosus treated with belimumab in clinical practice settings: OBSErve Spain multicentre study

Reumatología clinica, 2023-06, Vol.19 (6), p.312-318

2023

Volltextzugriff (PDF)

Description of a new family with cryopyrin-associated periodic syndrome: risk of visual loss in patients bearing the R260W mutation

Rheumatology (Oxford, England), 2014-06, Vol.53 (6), p.1095-1099

2014

Volltextzugriff (PDF)

Drug Retention Rate and Causes of Discontinuation of Adalimumab in Uveitis: Real-World Data from the Biotherapies in Uveitis (BioÚvea) Study Group

Ophthalmology (Rochester, Minn.), 2020-06, Vol.127 (6), p.814

2020

Volltextzugriff (PDF)

Long-term follow-up of certolizumab pegol in uveitis due to immune-mediated inflammatory diseases: multicentre study of 80 patients

Rheumatic & musculoskeletal diseases open, 2022-12, Vol.8 (2), p.e002693

2022

Volltextzugriff (PDF)

Fibromyalgia prevalence and associated factors in primary Sjögren's syndrome patients in a large cohort from the Spanish Society of Rheumatology registry (SJOGRENSER)

Clinical and experimental rheumatology, 2017-05, Vol.35 Suppl 105 (3), p.28

2017

Volltextzugriff (PDF)

Comparative Study of Infliximab Versus Adalimumab in Refractory Uveitis due to Behçet's Disease: National Multicenter Study of 177 Cases

Arthritis & rheumatology (Hoboken, N.J.), 2019-12, Vol.71 (12), p.2081-2089

2019

Volltextzugriff (PDF)

Cost-effectiveness analysis of Belimumab in patients with systemic lupus erythematosus in Spain

Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria, 2015-05, Vol.39 (3), p.161

2015

Volltextzugriff (PDF)

Anti-TNF-α therapy in patients with refractory uveitis due to Behçet's disease: a 1-year follow-up study of 124 patients

Rheumatology (Oxford, England), 2014-12, Vol.53 (12), p.2223-2231

2014

Volltextzugriff (PDF)

Comorbidities in Patients With Primary Sjögren's Syndrome and Systemic Lupus Erythematosus: A Comparative Registries‐Based Study

Arthritis care & research (2010), 2017-01, Vol.69 (1), p.38-45

2017

Volltextzugriff (PDF)

Efficacy, safety and cost-effectiveness of methotrexate, adalimumab or their combination in non-infectious non-anterior uveitis: a protocol for a multicentre, randomised, parallel three arms, active-controlled, phase III open label with blinded outcome assessment study

BMJ open, 2022-03, Vol.12 (3), p.e051378-e051378

2022

Volltextzugriff (PDF)

Report of an additional case of anti–tumor necrosis factor therapy and Listeria monocytogenes infection: Comment on the letter by Glück et al

Arthritis and rheumatism, 2003-06, Vol.48 (6), p.1764-1765

2003

Volltextzugriff (PDF)

Treatment with methotrexate in a patient with subglottic stenosis as initial manifestation of limited Wegener granulomatosis

Medicina clínica, 2004-02, Vol.122 (5), p.199

2004

Volltextzugriff (PDF)

Tocilizumab in patients with active rheumatoid arthritis and inadequate response to disease-modifying antirheumatic drugs or tumor necrosis factor inhibitors: subanalysis of Spanish results of an open-label study close to clinical practice

Reumatologia clinica, 2014-03, Vol.10 (2), p.94

2014

Volltextzugriff (PDF)

Systematic Review on the Effectiveness of Immunosuppressants and Biological Therapies in the Treatment of Autoimmune Posterior Uveitis

Seminars in arthritis and rheumatism, 2011-02, Vol.40 (4), p.314-323

2011

Volltextzugriff (PDF)

Infections in patients treated with tumor necrosis factor antagonists: incidence, etiology and mortality in the BIOBADASER registry

Medicina clinica, 2011-11, Vol.137 (12), p.533-540

2011

Volltextzugriff (PDF)

Adherence to synthetic disease-modifying Antirheumatic Drugs in Rheumatoid Arthritis: Results of the OBSERVAR Study

Reumatologia clinica, 2019-09, Vol.15 (5), p.264

2019

Volltextzugriff (PDF)

1 – 25 von 25

Suche als RSS-Feed

Aktive Filter

KollektionSpringer Nature - Complete Springer Journals

KollektionMEDLINE

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(22)
Mit Volltextzugriff
(15)

Publikationsform

Artikel
(25)

Sprache

Englisch
(24)
Spanisch
(4)

Erscheinungsjahr

n.n

Thema

Humans
(25)
Life Sciences & Biomedicine
(23)
Science & Technology
(23)
Female
(16)
Rheumatology
(16)
Male
(15)
Middle Aged
(14)
Treatment Outcome
(14)
Adult
(11)
Uveitis - Drug Therapy
(8)
Aged
(7)
Adolescent
(6)
Antirheumatic Agents - Therapeutic Use
(6)
Immunosuppressive Agents - Therapeutic Use
(6)
Spain
(6)
Uveitis
(6)
Antibodies, Monoclonal, Humanized - Therapeutic Use
(5)
Ophthalmology
(5)
Retrospective Studies
(5)
Young Adult
(5)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Prevalence and Incidence of Uveitis: A Systematic Review and Meta-analysis

Prevalence of uveitis in a Spanish population, UveCAM study

The effect of biologic therapy different from infliximab or adalimumab in patients with refractory uveitis due to Behçet's disease: results of a multicentre open-label study

Power Doppler ultrasonography assessment of entheses in spondyloarthropathies: response to therapy of entheseal abnormalities

Usefulness of Adalimumab in the Treatment of Refractory Uveitis Associated with Juvenile Idiopathic Arthritis

Treatment of Refractory Uveitis with Adalimumab: A Prospective Multicenter Study of 131 Patients

Cardiovascular Screening Practices and Statin Prescription Habits in Patients with Psoriasis among Dermatologists, Rheumatologists and Primary Care Physicians

Reduction of disease activity, corticosteroids use, and healthcare resource utilisation in patients with systemic lupus erythematosus treated with belimumab in clinical practice settings: OBSErve Spain multicentre study

Description of a new family with cryopyrin-associated periodic syndrome: risk of visual loss in patients bearing the R260W mutation

Drug Retention Rate and Causes of Discontinuation of Adalimumab in Uveitis: Real-World Data from the Biotherapies in Uveitis (BioÚvea) Study Group

Digestive involvement in primary Sjögren's syndrome: analysis from the Sjögrenser registry

Choroidal Thickness Is a Biomarker Associated With Response to Treatment in Ankylosing Spondylitis

Long-term follow-up of certolizumab pegol in uveitis due to immune-mediated inflammatory diseases: multicentre study of 80 patients

Fibromyalgia prevalence and associated factors in primary Sjögren's syndrome patients in a large cohort from the Spanish Society of Rheumatology registry (SJOGRENSER)

Comparative Study of Infliximab Versus Adalimumab in Refractory Uveitis due to Behçet's Disease: National Multicenter Study of 177 Cases

Cost-effectiveness analysis of Belimumab in patients with systemic lupus erythematosus in Spain

Anti-TNF-α therapy in patients with refractory uveitis due to Behçet's disease: a 1-year follow-up study of 124 patients

Comorbidities in Patients With Primary Sjögren's Syndrome and Systemic Lupus Erythematosus: A Comparative Registries‐Based Study

Efficacy, safety and cost-effectiveness of methotrexate, adalimumab or their combination in non-infectious non-anterior uveitis: a protocol for a multicentre, randomised, parallel three arms, active-controlled, phase III open label with blinded outcome assessment study

Report of an additional case of anti–tumor necrosis factor therapy and Listeria monocytogenes infection: Comment on the letter by Glück et al

Treatment with methotrexate in a patient with subglottic stenosis as initial manifestation of limited Wegener granulomatosis

Tocilizumab in patients with active rheumatoid arthritis and inadequate response to disease-modifying antirheumatic drugs or tumor necrosis factor inhibitors: subanalysis of Spanish results of an open-label study close to clinical practice

Systematic Review on the Effectiveness of Immunosuppressants and Biological Therapies in the Treatment of Autoimmune Posterior Uveitis

Infections in patients treated with tumor necrosis factor antagonists: incidence, etiology and mortality in the BIOBADASER registry

Adherence to synthetic disease-modifying Antirheumatic Drugs in Rheumatoid Arthritis: Results of the OBSERVAR Study

Aktive Filter

Suchergebnisse filtern